Navigation Links
Favrille in Medical News

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

...g Agreement with Seattle Genetics II-51 Celgene Agrees to Acquisition of Pharmion II-51 PerkinElmer Plans Acquisition of ViaCell II-51 favrille Announces Acquisition of Monoclonal Antibody Range from Diversa II-52 Johnson & Johnson Secures Contract worth US$112 Million II-52 Bi...

MyMedicalRecords, Inc. and Favrille, Inc. Close Merger

... needs." "We believe that the combination of favrille and MMR offers our creditors and stockholders the ..." Merger Overview For legal purposes, favrille is acquiring MMR although the combination will be ...ses. As consideration in the business combination, favrille has issued (or reserved for issuance) 92,599,196 s...

Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement

...21LOGO ) "We believe that the proposed merger of favrille and MMR is consistent with our objective of offeri...ere in the world. We believe this transaction with favrille will give MMR broader access to the investment com...saction Under the terms of the merger agreement, favrille will acquire all of the capital stock of MMR, in a...

Favrille Announces Listing on OTC Bulletin Board

...le's filings with the Securities and Exchange Commission. All forward-looking statements are qualified in their entirety by this cautionary statement. favrille is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-l...

Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting

.... About the Phase 3 Clinical Trial of Specifid favrille initiated a pivotal, double-blind, placebo control... from the U.S. Food and Drug Administration (FDA). favrille has also received Fast Track designation from the ...ed in their entirety by this cautionary statement. favrille is providing this information as of the date of th...
Favrille in Medical Technology

Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June

...mation and prepare for the analysis and unblinding of the trial in June." favrille initiated its Phase 3 randomized, placebo-controlled, double-blind registra...ng statements are qualified in their entirety by this cautionary statement. favrille is providing this information as of the date of this release and, except as...

Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results

...Based in part on the guidance provided by the DMB, favrille has determined April 2008 to be the appropriate ti...se 3 trial." Third Quarter 2007 Financial Review favrille also reported its financial results for the third ...f 2008." Conference Call and Webcast Information favrille management will host a conference call today to di...

Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma

...ient-specific, Id/KLH active immunotherapy for the treatment of B-cell NHL. favrille completed enrollment in its pivotal Phase 3 clinical trial of FavId followi...ng statements are qualified in their entirety by this cautionary statement. favrille is providing this information as of the date of this release and, except as...

Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkin's Lymphoma in Europe

...ient-specific, Id/KLH active immunotherapy for the treatment of B-cell NHL. favrille completed enrollment in its pivotal Phase 3 clinical trial of FavId followi...ng statements are qualified in their entirety by this cautionary statement. favrille is providing this information as of the date of this release and, except as...
Favrille in Biological Technology

Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger

...521LOGO ) "We are pleased to announce that favrille creditors holding more than 85% of the dollar valu...merger is subject to customary closing conditions, favrille meeting certain minimum cash requirements as of cl...and Where to Find It On November 13, 2008, favrille filed a Current Report on Form 8-K with the SEC th...

Favrille Announces Execution of Non-binding Term Sheet for a Merger Transaction

...on-binding term sheet for a reverse merger whereby favrille would acquire all of the capital stock of a privat...f MMR would own approximately 64% of the equity of favrille on a fully diluted basis. The existing equity holders of favrille would own approximately 29% of the Company. Approx...

Favrille Announces Receipt of Nasdaq Letters

...w the minimum $1.00 per share requirement and (ii) favrille has not maintained the $5,000,000 minimum market v...y. In accordance with Marketplace Rule 4450(e)(1), favrille has 90 calendar days, or until October 7, 2008, to...e with the minimum $1.00 per share requirement. If favrille does not regain compliance with either of the abov...

Favrille Announces Resolution of Debt Obligations and Plans for Maximizing Assets

...ll all unneeded fixed assets in the near future. favrille is currently in discussions with its landlord rega... options. The management and board of directors of favrille remain committed to addressing these issues and ma...ed in their entirety by this cautionary statement. favrille is providing this information as of the date of th...

Favrille Announces Workforce Reduction

...le's filings with the Securities and Exchange Commission. All forward-looking statements are qualified in their entirety by this cautionary statement. favrille is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-l...

Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma

...for their support and dedication." About the Phase 3 Registration Trial favrille initiated its Phase 3 randomized, placebo-controlled, double-blind registra...ng statements are qualified in their entirety by this cautionary statement. favrille is providing this information as of the date of this release and, except as...

Favrille Reports First Quarter 2008 Financial Results

...the first quarter of 2007. As of March 31, 2008, favrille had cash, cash equivalents and short-term investme...ng options." Phase 3 Registration Trial Update favrille reached the data cutoff date for its Phase 3 regis...trial. Conference Call and Webcast Information favrille management will host a conference call today to di...

Favrille Reports Fourth Quarter and Year End 2007 Financial Results

...e same periods in 2006. As of December 31, 2007, favrille had cash, cash equivalents and short-term investme...rille. Conference Call and Webcast Information favrille management will host a conference call today to di...ed in their entirety by this cautionary statement. favrille is providing this information as of the date of th...

Favrille Announces $21.1 Million Registered Direct Offering

...cal trials of longer duration in more patients are known. All forward-looking statements are qualified in their entirety by this cautionary statement. favrille is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-l...

Favrille to Present at BIO InvestorForum

...held at the Palace Hotel in San Francisco. (Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO ) Ms. Seymour will provide an overview of favrille and the clinical trials of its lead compound, FavId(R), which is currently in a pivotal Phase 3 clinical trial for the treatment of follicular B-cell ...
Other Tags
(Date:7/13/2014)... Fadhits.com is popular among worldwide women. Its lace ... Recently, the company has announced its new selection of ... all these outfits are available at discounted prices (from ... supplier is now offering similar discounts for many other ... many other designs for sale, including flower girl dresses, ...
(Date:7/13/2014)... July 13, 2014 A decreased ability to ... impairment and Alzheimer,s disease, while examinations of the ... protein associated with Alzheimer,s, in the brain, according ... today at the Alzheimer,s Association International Conference 2014 ... the studies, the decreased ability to identify odors ...
(Date:7/13/2014)... A Xarelto lawsuit webpage has been ... consumers with the most current information regarding serious internal ... medication, as well as the growing number of ... country. The law firm is now offering free legal ... internal bleeding and related complications while using Xarelto, including:, ...
(Date:7/13/2014)... July 13, 2014 Hope Palliative & Hospice ... grief support group at the Tamarack Senior Living Community in ... at 10:30 A.M. on the 3rd Wednesdays of every month. ... at the Tamarack Community located at 55 S. Greeley St. ... individuals and there is no cost for the group. ...
(Date:7/13/2014)... Wa (PRWEB) July 13, 2014 According ... by Vkool.com, this is a comprehensive guide that features ... deal with KP (keratosis pilaris). This guide ... 1: What Is Keratosis Pilaris? ,     Chapter 2: ... I Know If I Have KP? ,     Chapter ...
Breaking Medicine News(10 mins):Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 2Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 3Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 4Health News:Hope Hospice Announces Grief Support Group at the Tamarack Senior Living Community 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 3
(Date:7/11/2014)... exists that cannabinoid receptor type 1 can ... influx, and reduce neurotransmitter release. However, some ... can increase extracellular Ca2+ influx and increase ... team, Tongji Hospital Affiliated to Tongji Medical ... China used whole cell voltage-clamp and calcium ...
(Date:7/11/2014)... Using spider toxins to study the proteins that let ... say they have stumbled upon a biological tactic that ... insect plagues in a safe and environmentally responsible way. ... be lethal for one species and harmless for a ... target specific pests without harming beneficial species like bees. ...
(Date:7/10/2014)... Fe, Albuquerque, and other major cities in New Mexico, ... treated municipal wastewater rather than precious potable water supplies. ... 40% of all golf courses receive treated effluent. Reusing ... , Additionally, golf courses and homeowners alike fertilize their ... fertilizer is nitrate. A New Mexico State University turfgrass ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3'Tailored' water -- the latest in lawn care 2
Other Contents